Back
Virax Biolabs Group Ltd. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
VRAX
Virax Biolabs Group Ltd.
Last Price:
$0.39
Seasonality Move:
-34.96%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRAX is experiencing slight selling pressure.
Virax Biolabs Group Ltd. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.42 | Sell |
| 20-day SMA: | 0.45 | Sell |
| 50-day SMA: | 0.51 | Sell |
| 200-day SMA: | 0.81 | Sell |
| 8-day EMA: | 0.21 | Buy |
| 20-day EMA: | 0.1 | Buy |
| 50-day EMA: | 0.04 | Buy |
| 200-day EMA: | 0.01 | Buy |
Virax Biolabs Group Ltd. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 40.37 | Sell |
| Chaikin Money Flow: | -59606 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.37 - 0.53) | Sell |
| Bollinger Bands (100): | (0.47 - 0.71) | Sell |
Virax Biolabs Group Ltd. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Virax Biolabs Group Ltd. Stock
Is Virax Biolabs Group Ltd. Stock a Buy?
-
Virax Biolabs Group Ltd. share price is 0.39 while VRAX 8-day simple moving average is 0.42, which is a Sell signal.
-
The stock price of VRAX is 0.39 while Virax Biolabs Group Ltd. 20-day SMA is 0.45, which makes it a Sell.
-
Virax Biolabs Group Ltd. 50-day simple moving average is 0.51 while VRAX share price is 0.39, making it a Sell technically.
-
VRAX stock price is 0.39 and Virax Biolabs Group Ltd. 200-day simple moving average is 0.81, creating a Sell signal.
VRAX Technical Analysis vs Fundamental Analysis
Sell
48
Virax Biolabs Group Ltd. (VRAX)
is a Sell
Is Virax Biolabs Group Ltd. a Buy or a Sell?
-
Virax Biolabs Group Ltd. stock is rated a SellThe current Virax Biolabs Group Ltd. [VRAX] share price is $0.39. The Score for VRAX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Virax Biolabs Group Ltd. Stock Info
Market Cap:
2.6M
Price in USD:
0.39
Share Volume:
144.2K
Virax Biolabs Group Ltd. 52-Week Range
52-Week High:
3.20
52-Week Low:
0.35
Sell
48
Virax Biolabs Group Ltd. (VRAX)
is a Sell
Virax Biolabs Group Ltd. Share Price Forecast
-
What is the Virax Biolabs Group Ltd. stock price today?The Virax Biolabs Group Ltd. stock price is 0.39 USD today.
-
Will VRAX stock go up or go down?Virax Biolabs Group Ltd.> share price is forecast to RISE/FALL based on technical indicators
-
Is Virax Biolabs Group Ltd. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Virax Biolabs Group Ltd. is overvalued.
Is Virax Biolabs Group Ltd. Stock a Buy?
-
Virax Biolabs Group Ltd. share price is 0.39 while VRAX 8-day exponential moving average is 0.21, which is a Buy signal.
-
The stock price of VRAX is 0.39 while Virax Biolabs Group Ltd. 20-day EMA is 0.10, which makes it a Buy.
-
Virax Biolabs Group Ltd. 50-day exponential moving average is 0.04 while VRAX share price is 0.39, making it a Buy technically.
-
VRAX stock price is 0.39 and Virax Biolabs Group Ltd. 200-day simple moving average is 0.01, creating a Buy signal.
Fundamental Analysis of Virax Biolabs Group Ltd.
Is Virax Biolabs Group Ltd. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.47 per share.
Technical Analysis of Virax Biolabs Group Ltd.
Should I short Virax Biolabs Group Ltd. stock?
-
VRAX Moving Average Covergence Divergence (MACD) indicator is 0.07, suggesting Virax Biolabs Group Ltd. is a Buy
-
Virax Biolabs Group Ltd. Relative Strength Index (RSI) is 40.37, which suggest Virax Biolabs Group Ltd. is oversold
-
The Bollinger Bands (25) for Virax Biolabs Group Ltd. is (0.37 - 0.53), which suggest Virax Biolabs Group Ltd. is a Sell
-
The Bollinger Bands (100) for Virax Biolabs Group Ltd. is (0.47 - 0.71), which suggest Virax Biolabs Group Ltd. is a Sell
* Virax Biolabs Group Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.